nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamterene—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.13	0.197	CbGbCtD
Triamterene—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.122	0.185	CbGbCtD
Triamterene—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.122	0.185	CbGbCtD
Triamterene—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.11	0.167	CbGbCtD
Triamterene—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0926	0.14	CbGbCtD
Triamterene—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0837	0.127	CbGbCtD
Triamterene—Nephrolithiasis—Amprenavir—acquired immunodeficiency syndrome	0.00627	0.0253	CcSEcCtD
Triamterene—SCNN1G—vagina—acquired immunodeficiency syndrome	0.00619	0.0677	CbGeAlD
Triamterene—Calculus of kidney—Nelfinavir—acquired immunodeficiency syndrome	0.00611	0.0247	CcSEcCtD
Triamterene—Calculus of kidney—Stavudine—acquired immunodeficiency syndrome	0.00609	0.0246	CcSEcCtD
Triamterene—SCNN1D—lung—acquired immunodeficiency syndrome	0.00585	0.064	CbGeAlD
Triamterene—SCNN1G—lung—acquired immunodeficiency syndrome	0.00585	0.064	CbGeAlD
Triamterene—SCNN1A—digestive system—acquired immunodeficiency syndrome	0.00547	0.0598	CbGeAlD
Triamterene—SCNN1D—nervous system—acquired immunodeficiency syndrome	0.00542	0.0593	CbGeAlD
Triamterene—SCNN1B—vagina—acquired immunodeficiency syndrome	0.00523	0.0572	CbGeAlD
Triamterene—SCNN1D—central nervous system—acquired immunodeficiency syndrome	0.00522	0.0571	CbGeAlD
Triamterene—SCNN1A—blood—acquired immunodeficiency syndrome	0.00521	0.057	CbGeAlD
Triamterene—Nephrolithiasis—Nelfinavir—acquired immunodeficiency syndrome	0.00498	0.0201	CcSEcCtD
Triamterene—Nephrolithiasis—Stavudine—acquired immunodeficiency syndrome	0.00496	0.02	CcSEcCtD
Triamterene—SCNN1B—lung—acquired immunodeficiency syndrome	0.00495	0.0541	CbGeAlD
Triamterene—Calculus of kidney—Efavirenz—acquired immunodeficiency syndrome	0.00465	0.0188	CcSEcCtD
Triamterene—SCNN1B—nervous system—acquired immunodeficiency syndrome	0.00458	0.0501	CbGeAlD
Triamterene—SCNN1A—lung—acquired immunodeficiency syndrome	0.00457	0.05	CbGeAlD
Triamterene—SCNN1B—central nervous system—acquired immunodeficiency syndrome	0.00441	0.0482	CbGeAlD
Triamterene—Tubulointerstitial nephritis—Indinavir—acquired immunodeficiency syndrome	0.00421	0.017	CcSEcCtD
Triamterene—SCNN1D—brain—acquired immunodeficiency syndrome	0.00414	0.0453	CbGeAlD
Triamterene—Calculus of kidney—Ritonavir—acquired immunodeficiency syndrome	0.00411	0.0166	CcSEcCtD
Triamterene—Nephrolithiasis—Indinavir—acquired immunodeficiency syndrome	0.00401	0.0162	CcSEcCtD
Triamterene—SCNN1D—lymph node—acquired immunodeficiency syndrome	0.004	0.0438	CbGeAlD
Triamterene—Tubulointerstitial nephritis—Efavirenz—acquired immunodeficiency syndrome	0.00398	0.0161	CcSEcCtD
Triamterene—Calculus of kidney—Saquinavir—acquired immunodeficiency syndrome	0.00396	0.016	CcSEcCtD
Triamterene—Nephrolithiasis—Efavirenz—acquired immunodeficiency syndrome	0.00379	0.0153	CcSEcCtD
Triamterene—Renal failure acute—Didanosine—acquired immunodeficiency syndrome	0.00361	0.0146	CcSEcCtD
Triamterene—SCNN1B—brain—acquired immunodeficiency syndrome	0.0035	0.0383	CbGeAlD
Triamterene—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00342	0.0374	CbGeAlD
Triamterene—SCNN1B—lymph node—acquired immunodeficiency syndrome	0.00338	0.037	CbGeAlD
Triamterene—Nephrolithiasis—Ritonavir—acquired immunodeficiency syndrome	0.00335	0.0135	CcSEcCtD
Triamterene—SCNN1A—brain—acquired immunodeficiency syndrome	0.00324	0.0354	CbGeAlD
Triamterene—Nephrolithiasis—Saquinavir—acquired immunodeficiency syndrome	0.00323	0.013	CcSEcCtD
Triamterene—SCNN1A—lymph node—acquired immunodeficiency syndrome	0.00313	0.0342	CbGeAlD
Triamterene—Hyperkalaemia—Delavirdine—acquired immunodeficiency syndrome	0.00286	0.0116	CcSEcCtD
Triamterene—Hyperkalaemia—Saquinavir—acquired immunodeficiency syndrome	0.00255	0.0103	CcSEcCtD
Triamterene—Blood urea increased—Ritonavir—acquired immunodeficiency syndrome	0.00254	0.0103	CcSEcCtD
Triamterene—Renal failure acute—Indinavir—acquired immunodeficiency syndrome	0.00254	0.0102	CcSEcCtD
Triamterene—Renal failure acute—Efavirenz—acquired immunodeficiency syndrome	0.0024	0.00967	CcSEcCtD
Triamterene—Renal failure acute—Delavirdine—acquired immunodeficiency syndrome	0.00229	0.00925	CcSEcCtD
Triamterene—Jaundice—Nevirapine—acquired immunodeficiency syndrome	0.00225	0.0091	CcSEcCtD
Triamterene—Jaundice—Nelfinavir—acquired immunodeficiency syndrome	0.00218	0.00881	CcSEcCtD
Triamterene—Jaundice—Stavudine—acquired immunodeficiency syndrome	0.00217	0.00878	CcSEcCtD
Triamterene—Renal failure acute—Ritonavir—acquired immunodeficiency syndrome	0.00212	0.00856	CcSEcCtD
Triamterene—Renal failure acute—Saquinavir—acquired immunodeficiency syndrome	0.00204	0.00824	CcSEcCtD
Triamterene—Hypokalaemia—Efavirenz—acquired immunodeficiency syndrome	0.00201	0.00813	CcSEcCtD
Triamterene—Jaundice—Zidovudine—acquired immunodeficiency syndrome	0.00189	0.00763	CcSEcCtD
Triamterene—Jaundice—Indinavir—acquired immunodeficiency syndrome	0.00176	0.0071	CcSEcCtD
Triamterene—Photosensitivity reaction—Efavirenz—acquired immunodeficiency syndrome	0.00174	0.00704	CcSEcCtD
Triamterene—Hypokalaemia—Saquinavir—acquired immunodeficiency syndrome	0.00171	0.00692	CcSEcCtD
Triamterene—Dry mouth—Didanosine—acquired immunodeficiency syndrome	0.00167	0.00675	CcSEcCtD
Triamterene—Jaundice—Efavirenz—acquired immunodeficiency syndrome	0.00166	0.00671	CcSEcCtD
Triamterene—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.00164	0.00662	CcSEcCtD
Triamterene—Thrombocytopenia—Didanosine—acquired immunodeficiency syndrome	0.0016	0.00648	CcSEcCtD
Triamterene—Jaundice—Delavirdine—acquired immunodeficiency syndrome	0.00159	0.00642	CcSEcCtD
Triamterene—Fatigue—Amprenavir—acquired immunodeficiency syndrome	0.00155	0.00626	CcSEcCtD
Triamterene—Photosensitivity reaction—Ritonavir—acquired immunodeficiency syndrome	0.00154	0.00623	CcSEcCtD
Triamterene—Photosensitivity reaction—Saquinavir—acquired immunodeficiency syndrome	0.00149	0.006	CcSEcCtD
Triamterene—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.00147	0.00595	CcSEcCtD
Triamterene—Jaundice—Ritonavir—acquired immunodeficiency syndrome	0.00147	0.00593	CcSEcCtD
Triamterene—Dry mouth—Stavudine—acquired immunodeficiency syndrome	0.00145	0.00586	CcSEcCtD
Triamterene—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.00144	0.00583	CcSEcCtD
Triamterene—Jaundice—Saquinavir—acquired immunodeficiency syndrome	0.00141	0.00571	CcSEcCtD
Triamterene—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.0014	0.00566	CcSEcCtD
Triamterene—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.0014	0.00564	CcSEcCtD
Triamterene—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.00139	0.00563	CcSEcCtD
Triamterene—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.00137	0.00554	CcSEcCtD
Triamterene—Jaundice—Lamivudine—acquired immunodeficiency syndrome	0.00135	0.00545	CcSEcCtD
Triamterene—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.00131	0.0144	CbGeAlD
Triamterene—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.00129	0.00521	CcSEcCtD
Triamterene—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.00127	0.00513	CcSEcCtD
Triamterene—CYP1A2—blood—acquired immunodeficiency syndrome	0.00125	0.0137	CbGeAlD
Triamterene—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00124	0.00499	CcSEcCtD
Triamterene—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00123	0.00497	CcSEcCtD
Triamterene—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.00123	0.00495	CcSEcCtD
Triamterene—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00121	0.00489	CcSEcCtD
Triamterene—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.00121	0.00488	CcSEcCtD
Triamterene—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00121	0.00488	CcSEcCtD
Triamterene—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00118	0.00475	CcSEcCtD
Triamterene—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.00117	0.00474	CcSEcCtD
Triamterene—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00115	0.00464	CcSEcCtD
Triamterene—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00114	0.00462	CcSEcCtD
Triamterene—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00113	0.00458	CcSEcCtD
Triamterene—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00113	0.00457	CcSEcCtD
Triamterene—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00113	0.00455	CcSEcCtD
Triamterene—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.00113	0.00455	CcSEcCtD
Triamterene—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00112	0.00453	CcSEcCtD
Triamterene—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.00111	0.00448	CcSEcCtD
Triamterene—CYP1A2—lung—acquired immunodeficiency syndrome	0.0011	0.012	CbGeAlD
Triamterene—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00109	0.00438	CcSEcCtD
Triamterene—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00107	0.00431	CcSEcCtD
Triamterene—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.00107	0.00431	CcSEcCtD
Triamterene—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00106	0.0043	CcSEcCtD
Triamterene—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.00106	0.00428	CcSEcCtD
Triamterene—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00106	0.00427	CcSEcCtD
Triamterene—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00105	0.00425	CcSEcCtD
Triamterene—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00105	0.00423	CcSEcCtD
Triamterene—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00104	0.00421	CcSEcCtD
Triamterene—Rash—Didanosine—acquired immunodeficiency syndrome	0.00103	0.00417	CcSEcCtD
Triamterene—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00103	0.00417	CcSEcCtD
Triamterene—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00103	0.00417	CcSEcCtD
Triamterene—Headache—Didanosine—acquired immunodeficiency syndrome	0.00103	0.00415	CcSEcCtD
Triamterene—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00102	0.00414	CcSEcCtD
Triamterene—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00102	0.00412	CcSEcCtD
Triamterene—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00102	0.00411	CcSEcCtD
Triamterene—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00101	0.00407	CcSEcCtD
Triamterene—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00101	0.00406	CcSEcCtD
Triamterene—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000992	0.004	CcSEcCtD
Triamterene—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000981	0.00396	CcSEcCtD
Triamterene—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000977	0.00394	CcSEcCtD
Triamterene—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000974	0.00393	CcSEcCtD
Triamterene—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000974	0.00393	CcSEcCtD
Triamterene—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000959	0.00387	CcSEcCtD
Triamterene—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000944	0.00381	CcSEcCtD
Triamterene—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000944	0.00381	CcSEcCtD
Triamterene—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000942	0.0038	CcSEcCtD
Triamterene—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000941	0.0038	CcSEcCtD
Triamterene—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000937	0.00378	CcSEcCtD
Triamterene—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000937	0.00378	CcSEcCtD
Triamterene—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000929	0.00375	CcSEcCtD
Triamterene—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000928	0.00375	CcSEcCtD
Triamterene—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000927	0.00374	CcSEcCtD
Triamterene—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000923	0.00373	CcSEcCtD
Triamterene—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000908	0.00366	CcSEcCtD
Triamterene—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000906	0.00366	CcSEcCtD
Triamterene—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000905	0.00365	CcSEcCtD
Triamterene—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000901	0.00364	CcSEcCtD
Triamterene—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.0009	0.00363	CcSEcCtD
Triamterene—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000899	0.00363	CcSEcCtD
Triamterene—Rash—Stavudine—acquired immunodeficiency syndrome	0.000897	0.00362	CcSEcCtD
Triamterene—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000897	0.00362	CcSEcCtD
Triamterene—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000896	0.00362	CcSEcCtD
Triamterene—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000894	0.00361	CcSEcCtD
Triamterene—Headache—Stavudine—acquired immunodeficiency syndrome	0.000892	0.0036	CcSEcCtD
Triamterene—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000891	0.0036	CcSEcCtD
Triamterene—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000887	0.00358	CcSEcCtD
Triamterene—Rash—Abacavir—acquired immunodeficiency syndrome	0.000884	0.00357	CcSEcCtD
Triamterene—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000883	0.00357	CcSEcCtD
Triamterene—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000883	0.00357	CcSEcCtD
Triamterene—Headache—Abacavir—acquired immunodeficiency syndrome	0.000878	0.00355	CcSEcCtD
Triamterene—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000875	0.00353	CcSEcCtD
Triamterene—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000865	0.00349	CcSEcCtD
Triamterene—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000848	0.00342	CcSEcCtD
Triamterene—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000847	0.00342	CcSEcCtD
Triamterene—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000846	0.00342	CcSEcCtD
Triamterene—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000845	0.00341	CcSEcCtD
Triamterene—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000833	0.00336	CcSEcCtD
Triamterene—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000829	0.00335	CcSEcCtD
Triamterene—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000825	0.00333	CcSEcCtD
Triamterene—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000818	0.0033	CcSEcCtD
Triamterene—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000801	0.00323	CcSEcCtD
Triamterene—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000798	0.00322	CcSEcCtD
Triamterene—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000787	0.00318	CcSEcCtD
Triamterene—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000786	0.00318	CcSEcCtD
Triamterene—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00078	0.00315	CcSEcCtD
Triamterene—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00078	0.00315	CcSEcCtD
Triamterene—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000779	0.00315	CcSEcCtD
Triamterene—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000775	0.00313	CcSEcCtD
Triamterene—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000766	0.00309	CcSEcCtD
Triamterene—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000761	0.00307	CcSEcCtD
Triamterene—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000761	0.00307	CcSEcCtD
Triamterene—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000746	0.00301	CcSEcCtD
Triamterene—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000744	0.003	CcSEcCtD
Triamterene—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000735	0.00297	CcSEcCtD
Triamterene—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000731	0.00295	CcSEcCtD
Triamterene—Rash—Indinavir—acquired immunodeficiency syndrome	0.000725	0.00293	CcSEcCtD
Triamterene—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000725	0.00293	CcSEcCtD
Triamterene—Headache—Indinavir—acquired immunodeficiency syndrome	0.000721	0.00291	CcSEcCtD
Triamterene—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000719	0.0029	CcSEcCtD
Triamterene—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000711	0.00287	CcSEcCtD
Triamterene—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000708	0.00286	CcSEcCtD
Triamterene—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000691	0.00279	CcSEcCtD
Triamterene—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00069	0.00279	CcSEcCtD
Triamterene—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000688	0.00278	CcSEcCtD
Triamterene—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000685	0.00277	CcSEcCtD
Triamterene—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000685	0.00276	CcSEcCtD
Triamterene—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000683	0.00276	CcSEcCtD
Triamterene—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000682	0.00275	CcSEcCtD
Triamterene—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000681	0.00275	CcSEcCtD
Triamterene—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000664	0.00268	CcSEcCtD
Triamterene—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000661	0.00267	CcSEcCtD
Triamterene—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000658	0.00266	CcSEcCtD
Triamterene—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000656	0.00265	CcSEcCtD
Triamterene—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000655	0.00264	CcSEcCtD
Triamterene—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000651	0.00263	CcSEcCtD
Triamterene—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000651	0.00263	CcSEcCtD
Triamterene—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000646	0.00261	CcSEcCtD
Triamterene—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000636	0.00257	CcSEcCtD
Triamterene—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000634	0.00256	CcSEcCtD
Triamterene—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000633	0.00256	CcSEcCtD
Triamterene—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000618	0.00249	CcSEcCtD
Triamterene—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000612	0.00247	CcSEcCtD
Triamterene—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000611	0.00247	CcSEcCtD
Triamterene—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000606	0.00245	CcSEcCtD
Triamterene—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000606	0.00245	CcSEcCtD
Triamterene—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000604	0.00244	CcSEcCtD
Triamterene—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000602	0.00243	CcSEcCtD
Triamterene—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000588	0.00238	CcSEcCtD
Triamterene—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000584	0.00236	CcSEcCtD
Triamterene—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000584	0.00236	CcSEcCtD
Triamterene—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000583	0.00235	CcSEcCtD
Triamterene—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00058	0.00234	CcSEcCtD
Triamterene—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000571	0.00231	CcSEcCtD
Triamterene—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000561	0.00227	CcSEcCtD
Triamterene—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000557	0.00225	CcSEcCtD
Triamterene—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000556	0.00225	CcSEcCtD
Triamterene—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000553	0.00223	CcSEcCtD
Triamterene—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00055	0.00222	CcSEcCtD
Triamterene—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000524	0.00212	CcSEcCtD
